Chris Cardon, the Flemish who wants to develop the ideal vaccine: "We aim for double protection."
February 09, 2021
The young Belgian company Ziphius vaccines targets the coronavaccine market with its innovative technology. It aims for the ideal world: an mRNA vaccine that is 100% effective and only requires one dose. CEO Chris Cardon firmly believes it is possible.
By: Dirk Draulans
This article was published in "Knack" on February 09, 2021.